Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
PTHS
— Pelthos Therapeutics Inc.
AMEX
FULL STOCK PAGE →
Q2 2026 Earnings Call Summary
AUG 13, 2026
REVENUE
$15.6M
+43.1%
NET MARGIN
-150.1%
-56.2 PTS
EPS
-$6.62
-114.2%
FREE CASH FLOW
-$7.7M
+42.4%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 4
OLDER CALL →